| 000 | 01235 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516163433.0 | ||
| 264 | 0 | _c20130917 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a0031-7144 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohn, C | |
| 245 | 0 | 0 |
_aDefining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin. _h[electronic resource] |
| 260 |
_bDie Pharmazie _cJul 2013 |
||
| 300 |
_a622-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xmetabolism |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInactivation, Metabolic |
| 650 | 0 | 4 | _aMultidrug Resistance-Associated Protein 2 |
| 650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xmetabolism |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 |
_aPlatinum _xmetabolism |
| 700 | 1 | _aHäcker, H-G | |
| 700 | 1 | _aHilger, R A | |
| 700 | 1 | _aGütschow, M | |
| 700 | 1 | _aJaehde, U | |
| 773 | 0 |
_tDie Pharmazie _gvol. 68 _gno. 7 _gp. 622-7 |
|
| 999 |
_c22983574 _d22983574 |
||